North America
Oral solids, liquids, creams, ointments

Actavis has two finished-product manufacturing sites for solid, liquid and semi-solid dosage forms in North America; in Elizabeth, NJ and Lincolnton, NC.  

Elizabeth: Solid-oral-dose facility with capacity of four billion tablets and capsules, supporting a broad therapeutic range. Core competency in modified-release products.

Lincolnton: A growing production site for cream, ointment, liquid and suppository products serving the OTC, branded and Rx markets in the US.

These sites are supported by three Research & Development centers located in Elizabeth, NJ: Owings Mills, MD; and Sunrise, FL.